Suven Life rises on receiving product patents in Europe, Macau

The company has been granted a patent each by Europe and Macau for drug used to treat disorders associated with neurodegenerative diseases

Shares of Suven Life Sciences were up nearly 3% at Rs 269 on the BSE after the company said it has received product patents one each from Europe and Macau corresponding to the new chemical entities for the treatment of disorders associated with neurodegenerative diseases.

With these patents, the company now has twenty granted patents from Europe and eight granted patents from Macau, the company said in a release.

The patents are valid through 2030 and 2029, the release added.

The stock opened at Rs 264 and touched a high of Rs 275. At 10:55am, over 850,000 shares were traded on both the stock exchanges